iShares MSCI South Africa ETF vs GeneDx Holdings Corp — how do they compare? iShares MSCI South Africa ETF trades at $68.53, while GeneDx Holdings Corp trades at $82 (market cap $2.44B). The key difference: iShares MSCI South Africa ETF is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| EZA | WGS | |
|---|---|---|
Sector | Broad Market / Factor | Technology |
52-Week High | $81.60 | $167.51 |
52-Week Low | $56.57 | $34.51 |
Market Cap | — | $2.44B |
Enterprise Value | — | $2.48B |
Signals from Pluang's Aura AI — not financial advice
EZA trades at $68.33, down 2.01% today, with a bullish technical bias from moving averages but bearish oscillators. Key support is at $68 and resistance at $70. The company has a dividend scheduled for June 2026, but financial ratios like P/E and P/S are not provided in the data.
Outlook is mixed: technical strength contrasts with macroeconomic headwinds highlighted in recent news. Risks include exposure to South African sectors sensitive to interest rates and commodities. Investment appeal hinges on navigating these challenges amid a bullish trend signal.
GeneDx Holdings Corp (WGS) trades at $82.39, up 5.79% in the past 24 hours, with a bullish technical signal and strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating guidance, and returned to adjusted profitability earlier than expected. However, net income remains negative at -$106 million for 2026, and the stock faces class action lawsuits with an August 3, 2026 deadline.
Outlook is mixed: bullish technicals and analyst consensus suggest upside to the $90 price target, but fundamental weaknesses and legal risks pose significant challenges. Investment opportunity hinges on sustained revenue growth and margin improvement, while risks include profitability pressures and litigation outcomes.
Trailing returns across standard periods
EZA is a country-specific ETF that tracks the South African equity market. It provides exposure to large and mid-cap companies across key sectors like materials and financials, with top holdings such as AngloGold Ashanti and Naspers.
Read more on EZA →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →